BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24178246)

  • 1. Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis.
    Hoffman LR; Pope CE; Hayden HS; Heltshe S; Levy R; McNamara S; Jacobs MA; Rohmer L; Radey M; Ramsey BW; Brittnacher MJ; Borenstein E; Miller SI
    Clin Infect Dis; 2014 Feb; 58(3):396-9. PubMed ID: 24178246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences.
    Eng A; Hayden HS; Pope CE; Brittnacher MJ; Vo AT; Weiss EJ; Hager KR; Leung DH; Heltshe SL; Raftery D; Miller SI; Hoffman LR; Borenstein E
    BMC Microbiol; 2021 Sep; 21(1):247. PubMed ID: 34525965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of commensal proliferating
    Matamouros S; Hayden HS; Hager KR; Brittnacher MJ; Lachance K; Weiss EJ; Pope CE; Imhaus AF; McNally CP; Borenstein E; Hoffman LR; Miller SI
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1605-1610. PubMed ID: 29378945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis.
    Manor O; Levy R; Pope CE; Hayden HS; Brittnacher MJ; Carr R; Radey MC; Hager KR; Heltshe SL; Ramsey BW; Miller SI; Hoffman LR; Borenstein E
    Sci Rep; 2016 Mar; 6():22493. PubMed ID: 26940651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure.
    Hayden HS; Eng A; Pope CE; Brittnacher MJ; Vo AT; Weiss EJ; Hager KR; Martin BD; Leung DH; Heltshe SL; Borenstein E; Miller SI; Hoffman LR
    Nat Med; 2020 Feb; 26(2):215-221. PubMed ID: 31959989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis.
    Coffey MJ; Nielsen S; Wemheuer B; Kaakoush NO; Garg M; Needham B; Pickford R; Jaffe A; Thomas T; Ooi CY
    Sci Rep; 2019 Dec; 9(1):18593. PubMed ID: 31819107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal complications in cystic fibrosis.
    Redmond AO
    Practitioner; 1980 Mar; 224(1341):295-9. PubMed ID: 7403010
    [No Abstract]   [Full Text] [Related]  

  • 8. Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis.
    Debyser G; Mesuere B; Clement L; Van de Weygaert J; Van Hecke P; Duytschaever G; Aerts M; Dawyndt P; De Boeck K; Vandamme P; Devreese B
    J Cyst Fibros; 2016 Mar; 15(2):242-50. PubMed ID: 26330184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine.
    Dorsey J; Gonska T
    J Cyst Fibros; 2017 Nov; 16 Suppl 2():S14-S23. PubMed ID: 28986022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an Index Score for Intestinal Inflammation-Associated Dysbiosis Using Real-World Stool Test Results.
    Chen L; Reynolds C; David R; Peace Brewer A
    Dig Dis Sci; 2020 Apr; 65(4):1111-1124. PubMed ID: 31529411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis and the gastrointestinal tract.
    Duffield RA
    J Pediatr Health Care; 1996; 10(2):51-7. PubMed ID: 8847605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients - an unrecognized CF pathogen?
    Barillova P; Tchesnokova V; Dübbers A; Küster P; Peters G; Dobrindt U; Sokurenko EV; Kahl BC
    Int J Med Microbiol; 2014 May; 304(3-4):415-21. PubMed ID: 24630795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal pathophysiology and nutrition in cystic fibrosis.
    Ratchford TL; Teckman JH; Patel DR
    Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):853-862. PubMed ID: 30019967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical gastrointestinal disease in patients with cystic fibrosis of the pancreas.
    Blue SK; Shaffner LD
    N C Med J; 1971 May; 32(5):169-84. PubMed ID: 5283042
    [No Abstract]   [Full Text] [Related]  

  • 15. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota.
    Duytschaever G; Huys G; Bekaert M; Boulanger L; De Boeck K; Vandamme P
    J Cyst Fibros; 2013 May; 12(3):206-15. PubMed ID: 23151540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gstrointestinal manifestations of mucoviscidosis].
    Filipović D; Vulović D; Mikuska M; Radojković P
    Srp Arh Celok Lek; 1967 Dec; 95(12):1113-9. PubMed ID: 5189644
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered microbiota, fecal lactate, and fecal bile acids in dogs with gastrointestinal disease.
    Blake AB; Guard BC; Honneffer JB; Lidbury JA; Steiner JM; Suchodolski JS
    PLoS One; 2019; 14(10):e0224454. PubMed ID: 31671166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbiosis Signatures of Fecal Microbiota in South African Infants with Respiratory, Gastrointestinal, and Other Diseases.
    Krishnamoorthy S; Coetzee V; Kruger J; Potgieter H; Buys EM
    J Pediatr; 2020 Mar; 218():106-113.e3. PubMed ID: 31952848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey.
    Smith S; Rowbotham N; Davies G; Gathercole K; Collins SJ; Elliott Z; Herbert S; Allen L; Ng C; Smyth A
    BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32900780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Proportion of Bifidobacterium and
    Pardede SO; Paramastri KA; Hegar B; Rafli A
    Saudi J Kidney Dis Transpl; 2020; 31(5):898-904. PubMed ID: 33229754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.